Synergistic antiviral action of ribonucleotide reductase inhibitors and 3′-azido-3′-deoxythymidine on HIV type 1 infection in vitro

AIDS Research and Human Retroviruses

Volumn 12, Issue 8, 1996, Pages 677-682

  Giacca, Mauro ^a   Borella, Stefania ^b   Calderazzo, Francesca ^b   Bianchi, Luigi Chieco ^b   D'Agaro, Pierlanfranco ^c   Rampazzo, Chiara ^b   Bianchi, Vera ^b   Reichard, Peter ^b  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2' AZIDO 2' DEOXYCYTIDINE; HYDROXYUREA; NUCLEOSIDE ANALOG; OXIDOREDUCTASE INHIBITOR; RIBONUCLEOTIDE REDUCTASE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG TRANSFORMATION; DRUG UPTAKE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; VIRUS INHIBITION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELL CYCLE; CYTIDINE; DRUG SYNERGISM; ENZYME INHIBITORS; HIV CORE PROTEIN P24; HIV-1; HUMANS; HYDROXYUREA; LEUKOCYTES, MONONUCLEAR; PHOSPHORYLATION; REVERSE TRANSCRIPTASE INHIBITORS; RIBONUCLEOTIDE REDUCTASES; THYMINE NUCLEOTIDES; TUMOR CELLS, CULTURED; VIRUS REPLICATION; ZIDOVUDINE;

EID: 0029872850     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.677     Document Type: Article

References (17)

1. Karlsson A, Reichard P, and Eckstein F: Hydroxyurea increases the phosphorylation of 3′-fIuorothymidine and 3′-azidothymidine in CEM cells. Eur J Biochem 1989;186:689-694.
2. Bianchi V, Borella S, Calderazzo F, Ferraro P, Chieco Bianchi L, and Reichard P: Inhibition of ribonucleotide reductase by 2′-substituted deoxycytidine analogs: Possible application to AIDS treatment. Proc Natl Acad Sci USA 1994;91:8403-8407.
3. Durham JP and Ives DH: Deoxycytidine kinase. I. Distribution in normal and neoplastic tissues and interrelationships of deoxycytidine and 1-D-arabinofuranosyl cytosine phosphorylation. Mol Pharmacol 1969;5:358-375.
4. Gao WY, Cara A, Gallo RC, and Lori F: Low levels of deoxynucleotides in peripheral blood lymphocytes: A strategy to inhibit human immunodeficiency virus type 1 replication. Proc Natl Acad Sci USA 1993;90:8925-8928.
5. Lori F, Malykh A, Cara A, Sun D, Weinstein JN, Lisziewicz J, and Gallo RC: Hydroxyurea as an inhibitor of human immunodeficiency virus type 1 replication. Science 1994;266:801-805.
6. Gao WY, Johns DG, and Mitsuya H: Anti-human immunodeficiency virus type 1 activity of hydroxyurea in combination with 2′,3′-dideoxynucleosides. Mol Pharmacol 1994;46:767-772.
7. Malley SD, Grange JM, Hamedi-Sangsari F, and Vila JR: Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2′,3′-dideoxyinosine in infected resting human lymphocytes. Proc Natl Acad Sci USA 1994;91:11017-11021.
8. Gao WY, Johns DG, Chokekijchai S, and Mitsuya H: Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2′,3′-dideoxynucleoside activities against replication of human immunodeficiency virus. Proc Natl Acad Sci USA 1995;92:8333-8337.
9. Giacca M, Zanussi S, Comar M, Simonelli C, Vaccher E, de Paoli P, and Tirelli U: Treatment of HIV infection with hydroxyurea: Virological and clinical evaluation. J Infect Dis (in press).
10. Åkerblom L and Reichard P: Azidocytidine is a specific inhibitor of deoxyribonucleotide synthesis in 3T6 cells. J Biol Chem 1985;260:9197-9202.
11. Sherman PA and Fyfe AJ: Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers. Anal Biochem 1989;180:222-226.
12. Bianchi V, Ferraro P, Borella S, Bonvini P, and Reichard P: Effects of mutational loss of nucleoside kinases on deoxyadenosine 5′-phosphate/deoxyadenosine substrate cycle in cultured CEM and V79 cells. J Biol Chem 1994;269:16677-16683.
13. Yoshioka A, Tanaka S, Hiaraoka O, Koyama Y, Hirota Y, Ayusawa D, Seno T, Garrett C, and Wataya Y: Deoxyribonucleoside triphosphate imbalance: 5-Fluoro-deoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J Biol Chem 1987;262:8235-8241.
14. Johnson MA and Fridland A: Phosphorylation of 2′,3′-dideoxyinosine by cytosolic 5′-nucleotidase of human lymphoid cells. Mol Pharmacol 1989;36:291-295.
15. Bianchi V, Pontis E, and Reichard P: Changes of deoxyribonucleoside triphosphate pools induced by hydroxyurea and their relation to DNA synthesis. J Biol Chem 1986;261:16037-16042.
16. Jacobsson B, Britton S, He Q, Karlsson A, and Eriksson S: Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: Implications for zidovudine metabolism. Aids Res Hum Retroviruses 1995;11:805-811.
17. Meyerhans A, Vartanian JP, Hultgren C, Plikat U, Karlsson A, Wang L, Eriksson S, and Wain-Hobson S: Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J Virol 1994;68:535-540.